Background Nonalcoholic fatty liver disease (NAFLD) is a prevalent disorder associated with
obesity and diabetes. Few treatment options are effective for patients with NAFLD, but …

Nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver in the absence
of secondary causes. NAFLD is a multifactorial disease that results from the interaction of …

The incidence of nonalcoholic fatty liver disease (NAFLD) continues to increase with
prevalence estimates ranging from 17%–33%, making it is the most common cause of …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly important cause of chronic liver
disease globally. Similar to metabolic syndrome and obesity, NAFLD is associated with …

Background & aims Non-alcoholic fatty liver disease (NAFLD) is a common, multifactorial
liver disease with rapidly increasing prevalence. During the past decade, several lines of …

Nonalcoholic fatty liver disease (NAFLD) is diagnosed across the age spectrum and
contributes to significant morbidity and mortality. The pathophysiology of NAFLD is not …

The gut microbiome, a diverse microbial community in the gastrointestinal tract, plays a
pivotal role in the maintenance of health. The gut microbiome metabolizes dietary and host …

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease, with
a prevalence that is increasing in parallel with the global rise in obesity and type 2 diabetes …

Nonalcoholic fatty liver disease is the hepatic expression of metabolic syndrome, being
frequently associated with obesity, insulin resistance, and dyslipidemia. Recent lines of …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …